Robert Andrew Douglas Resmed Inc (RSMDF) insider trading activity

Robert Andrew Douglas is Special Advisor of RESMED INC. Currently has a direct ownership of 13,849 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 15, 2021, when has been sold 8,000 shares (ResMed Common Stock) at a price of $271.75 per share, resulting in proceeds of $2,174,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

0% 3M change

74.14% 12M change

Total Value Held $0

Robert Andrew Douglas Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2021	SELL Open market or private sale	$2,174,000 $271.75 p/Share	8,000 Reduced 27.34%	21,266 ResMed Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 21.47%	29,266 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$245,199 $259.47 p/Share	945 Reduced 4.25%	21,266 ResMed Common Stock
Oct 15 2021	SELL Open market or private sale	$2,046,160 $255.77 p/Share	8,000 Reduced 26.53%	22,149 ResMed Common Stock
Oct 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 20.97%	30,149 ResMed Common Stock
Sep 15 2021	SELL Open market or private sale	$2,334,640 $291.83 p/Share	8,000 Reduced 26.53%	22,149 ResMed Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 20.97%	30,149 ResMed Common Stock

Aug 19 2021	BUY Grant, award, or other acquisition	-	5,382 Added 19.55%	22,149 ResMed Common Stock
Aug 16 2021	SELL Open market or private sale	$2,204,560 $275.57 p/Share	8,000 Reduced 32.3%	16,767 ResMed Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.41%	24,767 ResMed Common Stock
Jul 15 2021	SELL Open market or private sale	$1,984,000 $248.0 p/Share	8,000 Reduced 32.3%	16,767 ResMed Common Stock
Jul 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.41%	24,767 ResMed Common Stock
Jun 15 2021	SELL Open market or private sale	$1,856,800 $232.1 p/Share	8,000 Reduced 32.3%	16,767 ResMed Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 24.41%	24,767 ResMed Common Stock
May 17 2021	SELL Open market or private sale	$1,560,000 $195.0 p/Share	8,000 Reduced 47.72%	8,766 ResMed Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$465,920 $58.24 p/Share	8,000 Added 32.3%	16,767 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	4,099 Added 19.71%	16,701 ResMed Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$7,506,881 $214.74 p/Share	34,958 Reduced 42.61%	47,080 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$12,681,901 $214.74 p/Share	59,057 Added 41.86%	82,038 ResMed Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$364,193 $212.11 p/Share	1,717 Reduced 6.95%	22,981 ResMed Common Stock

Also insider at

GMED

GLOBUS MEDICAL INC Healthcare

RAD